Literature DB >> 27465560

[The wearable cardioverter/defibrillator : Temporary protection from sudden cardiac death].

D Duncker1, J Bauersachs2, C Veltmann2.   

Abstract

In the majority of cases sudden cardiac death (SCD) is caused by ventricular tachyarrhythmia. Implantable cardioverter-defibrillators (ICD) represent an evidence-based and established method for prevention of SCD. For patients who do not fulfill the criteria for guideline-conform implantation of an ICD but still have an increased, e.g. transient risk for SCD, a wearable cardioverter-defibrillator (WCD) vest was developed to temporarily prevent SCD. Numerous studies have shown the safety and efficacy of the WCD, although there is still a gap in evidence concerning a reduction in overall mortality and improvement in prognosis. This article gives an overview on the currently available literature on WCD, the indications, potential risks and complications.

Entities:  

Keywords:  Cardiomyopathy; Mortality; Risk stratification; Tachycardia, ventricular; Ventricular fibrillation

Mesh:

Year:  2016        PMID: 27465560     DOI: 10.1007/s00108-016-0110-2

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  28 in total

Review 1.  Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy.

Authors:  Karen Sliwa; Denise Hilfiker-Kleiner; Mark C Petrie; Alexandre Mebazaa; Burkert Pieske; Eckhart Buchmann; Vera Regitz-Zagrosek; Maria Schaufelberger; Luigi Tavazzi; Dirk J van Veldhuisen; Hugh Watkins; Ajay J Shah; Petar M Seferovic; Uri Elkayam; Sabine Pankuweit; Zoltan Papp; Frederic Mouquet; John J V McMurray
Journal:  Eur J Heart Fail       Date:  2010-08       Impact factor: 15.534

2.  Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction.

Authors:  Ilan Goldenberg; Anant K Vyas; W Jackson Hall; Arthur J Moss; Hongyue Wang; Hua He; Wojciech Zareba; Scott McNitt; Mark L Andrews
Journal:  J Am Coll Cardiol       Date:  2008-01-22       Impact factor: 24.094

Review 3.  [Primary and secondary prophylactic ICD therapy in congenital electrical and structural cardiomyopathies].

Authors:  D Duncker; T König; S Hohmann; C Veltmann
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2015-05-22

4.  Early risk of mortality after coronary artery revascularization in patients with left ventricular dysfunction and potential role of the wearable cardioverter defibrillator.

Authors:  Edwin T Zishiri; Sarah Williams; Edmond M Cronin; Eugene H Blackstone; Stephen G Ellis; Eric E Roselli; Nicholas G Smedira; A Marc Gillinov; Jo Ann Glad; Patrick J Tchou; Steven J Szymkiewicz; Mina K Chung
Journal:  Circ Arrhythm Electrophysiol       Date:  2012-12-28

Review 5.  The Wearable Cardioverter/Defibrillator - Toy Or Tool?

Authors:  David Duncker; Christian Veltmann
Journal:  J Atr Fibrillation       Date:  2016-04-30

6.  Use of a wearable defibrillator in terminating tachyarrhythmias in patients at high risk for sudden death: results of the WEARIT/BIROAD.

Authors:  Arthur M Feldman; Helmut Klein; Patrick Tchou; Srinivas Murali; W Jackson Hall; Donna Mancini; John Boehmer; Mark Harvey; M Stephen Heilman; Steven J Szymkiewicz; Arthur J Moss
Journal:  Pacing Clin Electrophysiol       Date:  2004-01       Impact factor: 1.976

7.  Evaluation of the effectiveness of a wearable cardioverter defibrillator detection algorithm.

Authors:  Katie A Dillon; Steven J Szymkiewicz; Thomas E Kaib
Journal:  J Electrocardiol       Date:  2010 Jan-Feb       Impact factor: 1.438

8.  Wearable cardioverter-defibrillator use in patients perceived to be at high risk early post-myocardial infarction.

Authors:  Andrew E Epstein; William T Abraham; Nicole R Bianco; Karl B Kern; Michael Mirro; Sunil V Rao; Edward K Rhee; Scott D Solomon; Steven J Szymkiewicz
Journal:  J Am Coll Cardiol       Date:  2013-07-31       Impact factor: 24.094

Review 9.  Current management of patients with severe acute peripartum cardiomyopathy: practical guidance from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy.

Authors:  Johann Bauersachs; Mattia Arrigo; Denise Hilfiker-Kleiner; Christian Veltmann; Andrew J S Coats; Maria G Crespo-Leiro; Rudolf A De Boer; Peter van der Meer; Christoph Maack; Frederic Mouquet; Mark C Petrie; Massimo F Piepoli; Vera Regitz-Zagrosek; Maria Schaufelberger; Petar Seferovic; Luigi Tavazzi; Frank Ruschitzka; Alexandre Mebazaa; Karen Sliwa
Journal:  Eur J Heart Fail       Date:  2016-06-23       Impact factor: 15.534

10.  Evolution of left ventricular ejection fraction after acute myocardial infarction: implications for implantable cardioverter-defibrillator eligibility.

Authors:  Johanna Sjöblom; Josephine Muhrbeck; Nils Witt; Mahbubul Alam; Viveka Frykman-Kull
Journal:  Circulation       Date:  2014-07-29       Impact factor: 29.690

View more
  1 in total

Review 1.  [Ventricular arrhythmias : What has been confirmed in therapy?]

Authors:  D Duncker; J Bauersachs; C Veltmann
Journal:  Internist (Berl)       Date:  2017-12       Impact factor: 0.743

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.